1. Low glycosylated ferritin is a sensitive biomarker of severe COVID-19
- Author
-
Pascal Sève, Maxime Fauter, Sébastien Viel, Yvan Jamilloux, Pierre Pradat, Marine Villard, Lorna Garnier, Sabine Zaepfel, Thomas Henry, Thierry Walzer, and Julie Fiscus
- Subjects
Adult ,Male ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Pneumonia, Viral ,Immunology ,Betacoronavirus ,Prognostic markers ,Internal medicine ,Correspondence ,medicine ,Humans ,Immunology and Allergy ,Prospective Studies ,Pandemics ,Aged ,Aged, 80 and over ,biology ,business.industry ,SARS-CoV-2 ,Disease progression ,COVID-19 ,Diagnostic markers ,Middle Aged ,Ferritin ,Hospitalization ,Endocrinology ,Infectious Diseases ,Ferritins ,biology.protein ,Disease Progression ,Biomarker (medicine) ,Female ,business ,Coronavirus Infections ,Biomarkers - Published
- 2020
- Full Text
- View/download PDF